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ABSTRACT
Advanced glycation end products (AGEs) have been thought to be a major cause of diabetic nephropathy (DN).
The mechanisms underlying the involvement of AGEs antibody in diabetic nephropathy are not fully understood.
The present study was designed to investigate the protective effect of AGEs antibody on AGEs-induced glomerular
damage. Isolated glomeruli were pre-incubated either with 10 µg/mL polyclonal anti-AGEs antibody (AGE-pAb)
or  monoclonal  anti-Nɜ-carboxymethyl-lysine  antibody  (CML-mAb)  as  a  model  of  AGEs  antibody  to  block
interaction of AGEs with receptor for AGEs (RAGE) and incubated afterwards either with 100 µg/mL bovine
serum albumin (BSA) or AGE-modified bovine serum albumin (AGE-BSA) for 48 h. Annexin V/nephrin double-
staining was performed to determine apoptosis.  Using immunofluorescence,  we found that  administration of
AGE-BSA not only significantly increased glomerular cells apoptosis and nuclear factor kappa B (NF-ĸB) p65
expression, but also reduced expression of nephrin, an important structural and signal molecule of podocytes slit
diaphragm. Blocking the interaction of AGE-RAGE with AGEs antibody significantly protected glomerular cells
from AGEs-induced  apoptosis  and  NF-ĸB  p65  overexpression.  We  found  that  AGE-pAb  conferred  superior
protective effect compared with CmL-mAb for the same reduction in apoptosis and NF-ĸB p65 expression. In
sharp contrast, CmL-mAb led to preserve expression of podocytes nephrin better than AGE-pAb. These results
demonstrate that the antibody against AGEs may be beneficial for preventing the glomerular damage in DN. 
Keywords: Advanced glycation end products; antibody, apoptosis, diabetic nephropathy, Ne-(carboxymethyl)lysine 
Diabetes mellitus (DM) is a significant health prob-
lem with  a  worldwide  mortality  around  382  million
people in 2013, and this number is expected to rise to
592 million by 2035 [1]. AGEs are a causative factor in
diabetic  vascular  complication  such  as  diabetic
nephropathy (DN) which further lead to end-stage re-
nal disease [2,3]. Accumulation of AGEs is present in
all  renal compartments in diabetic patient with three
mechanisms of toxicity include interaction AGEs with
receptor for AGE (RAGE), in situ glycation and tissue
deposition [4]. Inhibition of AGEs is widely regarded
as an implicit goal in clinical medicine for the treat-
ment of DN [5]. So far,  most studies have been fo-
cused on the potential of therapies that not only target
various pathways upregulated by AGEs, but also target
AGEs  itself  by  preventing  AGE formation,  breaking
AGE-protein  cross-linking,  or  neutralizing  AGE  [6–
11]. In addition to the development of anti-AGE activ-
ity from natural product or synthetic compound, im-
munization of AGEs in diabetic mice has recently at-
tached attention [12].
AGEs have antigenic properties that may exert an
autoimmune  response.  Autoantibodies  against  AGEs
are detected in serum of patients with DM and non-
DM which may play a role in the macrophage uptake
of  AGEs-modified  protein  via  AGEs-immune  com-
plexes (AGE-IC) formation [13,14]. Disruption of the
balance between AGEs formation and AGEs elimina-
tion will lead to accumulation of AGEs [14,15]. How-
JTLS | J. Trop. Life. Science 176 Volume 6 | Number 3 | September | 2016
INTRODUCTION
 
*Corresponding author:
Oktavia Rahayu Adianingsih
Laboratory of Pharmacy, Faculty of Medicine, Brawijaya University
Jalan Veteran, Malang, East Java 65145, Indonesia
E-mail: oktavia.rahayu@ub.ac.id
doi: 10.11594/jtls.06.03.08
How to cite:
Adianingsih OR, Lyrawati D, Samsu N (2016) Advanced Glycation 
End Products (AGEs) Antibody Protects Against AGEs-
Induced Apoptosis and NF-ĸB p65 Subunit Overexpression in
Rat Glomerular Culture. J. Trop. Life. Science 6 (3): 176 – 183.
Oktavia R Adianingsih, Diana Lyrawati, Nur Samsu, 2016
ever, our knowledge of the molecular mechanism gov-
erning role of AGE-Ab and AGE-IC in diabetic com-
plication is still very limited. Thus, in this research, we
aimed to demonstrate the role of AGE-Ab in prevent
AGEs-induced glomerular damage. 
Ethics
This research was approved by the Health Research
Ethics Commission from Faculty of Medicine, Brawi-
jaya  University,  Malang,  Indonesia,  with  registration
number 356B/EC/KEPK-S2/06/2015.
Chemicals
All  chemicals  were  purchased  from  Sigma  (St.
Louis, MO) unless otherwise indicated. AGE-mAb was
purchased from Circulex (Nagano,  Japan).  AGE-pAb
was  purchased  from  Abcam  (Cambridge,  England).
BSA (fraction V) was purchased from Roche Diagnos-
tic GmbH (Mannheim, Germany). AGE-BSA was pur-
chased  from  BioVision  (California,  USA).  For  im-
munofluorescence  assay,  the  following  primary  anti-
bodies  were  used:  rabbit  polyclonal  anti-NF-ĸB  p65
(Bioss,  Woburn, USA),  goat monoclonal  anti-nephrin
(Santa  Cruz  Biotechnology,  California,  USA),  rabbit
polyclonal anti-nephrin (Bioss, Woburn, USA) and An-
nexin V conjugated fluorescein-isothiocyanate (FITC)
(BioLegend, Fell, Germany). Secondary antibodies were
used: goat anti-rabbit IgG-FITC, rabbit anti-goat IgG-
rhodamine and goat anti-rabbit IgG-rhodamine (Santa
Cruz  Biotechnology,  California,  USA).  Fetal  bovine
serum (FBS) was purchased from Gibco (Grand Island,
NY, USA).
Rat glomerular isolation and culture
Isolation and culture of glomeruli were done as de-
scribed  previously  with  some  modifications  [16–19].
Briefly, male Wistar rats at age 7 - 9 weeks were sacri-
ficed by cervical dislocation and perfused with ice-cold
Hank’s  balanced  salt  solution  (HBSS)  through  the
heart. The kidneys were perfused with ice-cold HBSS
and dissected into small pieces (1 - 2 mm3 cubes) with
a  surgical  blade  in  ice-cold  HBSS.  Next,  the  tissues
were  digested  in  collagenase  solution  containing  1
mg/mL collagenase A in HBSS at 37oC for 1 hour with
gentle agitation. The collagenase-digested tissues were
gently pressed through a 100 µm cell strainer (BD Bio-
science,  Bedford,  USA),  followed by flushing  with 5
mL of ice-cold sterile HBSS. The cell suspension was
then centrifuged at 200 × g for 5 minutes. The super-
natant  was  discarded  and  the  cell  pellet  was  resus-
pended in 2 mL of ice-cold HBSS. Glomeruli were iso-
lated manually with micro-hematocrit tube and trans-
ferred at least two times into another dish to remove
any remaining  debris  which  included when isolation
process. All procedure were performed on ice, except
for the collagenase digestion. Isolated glomeruli  were
cultured on type I collagen-coated glass-bottom culture
dishes (MatTek Corporation, Ashland, MA) in RPMI
1640 medium containing 10% FBS supplemented with
10% penicillin-streptomycin and 1% insulin-transfer-
rin-selenium  A  liquid  media  supplement.  Glomeruli
were cultured at 37oC in a moist 95% air/5% CO2 at-
mosphere. 
Incubation of glomeruli with AGEs and blocking with
AGEs antibody
Treatment was performed after 3 days of culture of
isolated glomeruli.  To block the binding of AGEs to
RAGE,  10  µg/mL AGE-pAb or  AGE-mAb pre-incu-
bated for 1 hour before 100 µg/mL BSA or AGE-BSA
were  added  for  48  hours.  All  experiments  were  re-
peated two times in each indicated condition.
Double labelling immunofluorescence staining
The  indirect  immunofluorescence  technique  was
applied to fixated glomeruli.  Double labelling of cul-
tured glomeruli was performed to evaluate the effect of
AGE-Ab on AGEs-induced apoptosis and NF-ĸB p65
expression. In brief, after being incubated with AGE-
BSA in the absence or pre-treatment of AGE-Ab with a
1 hour interval, glomeruli on glass bottom dish were
fixed  with  4%  paraformaldehyde  for  15  minutes,
washed with PBS three times, permeabilized with 2%
Triton X-100 for 5 minutes, blocked with blocking so-
lution (2% BSA and 2% FBS in PBS) for 30 minutes,
and incubated with primary antibody for 1 hour. For
double-label immunostaining of NF-ĸB p65 expression,
anti-NF-ĸB  p65  and  anti-nephrin  primary  antibody
were premixed as follows and applied simultaneously.
After washing with PBS three times, glomeruli were in-
cubated  with  fluorescein  isothiocyanate  (FITC)-  and
rhodamine-conjugated secondary antibody for 1 hour,
then washed again with PBS three  times.  Sequential
double  staining  was  performed to  evaluate  apoptosis
using FITC-conjugated annexin V for 1 hour, blocked
with blocking solution for 30 minutes, incubated with
anti-nephrin primary antibody for 1 hour, and then in-
cubated  with  rhodamine-conjugated  secondary  anti-
body for 1 hour. The negative control was performed
using 2% BSA in PBS instead of the primary antibody.
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Quantitative imaging
Fluorescence images were acquired using confocal
laser  scanning  microscope (Fluoview FV1000,  Olym-
pus, Tokyo, Japan) and recorded on a computer using
the Olympus Fluoview ver 1.7a viewer. The expression
of protein was determined as described previously [19].
Digital  pictures  of  the  green  and red  channels  were
quantitated using the ImageJ 1.50 software (NIH, MD,
USA). Three fields were selected for analysis of each
stain.  The  images  were  converted  to  8-bit  grayscale.
Then,  an  outline  was  drawn around  each  glomeruli
and selected as the region of interest (ROI) to measure
area (A) and integrated density (ID) of fluorescence.
Next,  the  mean  gray  value  of  background  readings
(MGV) was measured by selecting five distinct areas in
the  background with  no  fluorescence.  The  corrected
optical density (COD) = ID – (A Ö × MGV), was cal-
culated.  Data  were  plotted  using  Prism 6.0  software
(GraphPad, San Diego, CA, USA).
Statistical analysis
All data are presented as mean ± SD of two inde-
pendent experiments. The statistical analysis was per-
formed using the IBM SPSS Statistics 20 software for
Windows (IBM Corp.,  Armonk,  NY,  USA).  Differ-
ences  between  groups  were  determined  by  Kruskal-
Wallis  tests,  followed by Mann-Whitney post-tests to
calculate  statistical  significance.  Correlation  analyses
between variables were evaluated using the non-para-
metric Spearman rank coefficient. Group differences at
the level of p < 0.05 were considered statistically signif-
icant. 
The previous study demonstrated that AGEs accu-
mulation resulted in glomerular damage by activating
RAGE in podocyte,  endothelial  cells,  mesangial cells,
and  tubular  cells  [4].  In  this  study,  we provided  in
vitro  evidences  that  blocking  AGE-RAGE interaction
with  AGEs  antibody  protects  glomerular  cells  from
apoptosis and NF-ĸB overexpression induced by AGEs.
To the best of our knowledge, this is the first  study
demonstrating that AGEs antibody protects glomerular
damage  induced  by  AGEs.  Previously  study  demon-
strated that AGE-RAGE interaction can also be inhib-
ited  by  pre-incubation  of  RAGE-Ab.  This  antibody
protects functional and morphological damages of hu-
man  podocytes  induced  by  peritoneal  dialysis  fluid-
and glucose degradation products [20].
AGEs  antibody  down-regulated  AGEs-induced
glomerular NF-ĸB p65 overexpression 
To examine the effect of AGEs on NF-ĸB p65 ex-
pression  in  glomerular  cells,  we  pre-incubated
glomeruli  with AGE-pAb or AGE-mAb before AGE-
BSA exposure. As shown in Figure 1A-B, AGEs signi-
ficantly  increased  NF-ĸB  p65  expression  in  cultured
glomeruli. However, AGEs-induced over-expression of
NF-ĸB p65 was significantly inhibited by preincubation
of  AGE-Ab.  AGE-pAb significantly  decreased  NF-ĸB
p65 expression better than AGE-mAb. Since nephrin
expression has been associated with podocyte survival,
we studied the effect  of AGE-Ab on nephrin expres-
sion. The presence of AGE-BSA significantly reduced
nephrin expression, thus increased NF-ĸB/nephrin ex-
pression ratio (Figure 1C). Both AGE-pAb and CmL-
mAb significantly reduced NF-ĸB/nephrin expression
ratio  compared  with  AGE-BSA-treated  group.  These
findings indicated that AGE-Ab down-regulated AGEs-
induced NF-ĸB p65 over-expression.
AGEs are believed to play a major role in the de-
velopment of DN. Interaction of AGE-RAGE acti-vates
a series of  intracellular  signaling pathway,  inclu-ding
NF-ĸB transcription factor which initiates and stimu-
lates  the  production  of  pro-inflammatory  mole-cules
that  contribute  to  the  pathogenesis  of  DN [3].  Our
study  showed  that  AGE-BSA  increased  glome-rular
NF-ĸB p65 expression. This finding supported by Bier-
haus et al. [21] that binding AGEs to RAGE results in
sustained activation of NF-ĸB as the result of increased
levels of de novo synthesized NF-ĸB p65. Sustained ac-
tivation NF-ĸB is  mediated  by initial  degradation of
IĸB protein followed by new synthesis of NF-ĸB p65
mRNA and protein in the presence of newly synthe-
sized IĸBα and IĸBb [21]. Research conducted by Peng
et al. [22] showed that AGEs signal via RAGE gener-
ates a signal-specific post-translational modification, or
a “barcode” to NF-κB that mediates a specific gene ex-
pression pattern. AGE-RAGE signaling results in NF-
ĸB activation via phosphorylation of NF-ĸB p65 sub-
unit at T254, S311, S536 residues [22]. AGEs also in-
duces NF-ĸB activation mediated by suppression of sir-
tuin 1 (SIRT1) expression in podo-cytes, which leads
acetylation of NF-ĸB p65 subunit [23].
Unlike  many  other  receptors,  the  activation  of
RAGE by AGEs positively upregulates RAGE expres-
sion, resulting in sustained RAGE signaling through a
NF-ĸB-dependent mechanism [24,25]. Moreover,  acti-
vation of NF-ĸB also upregulates  AGEs formation via 
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Figure 1. AGEs  antibody  downregulated  glomerular  NF-ĸB  p65  expression  induced  by  AGEs.  A.  Representative  confocal
microscopic images of NF-ĸB p65 (green) and nephrin (red) fluorescence in the glomeruli. BSA was chosen as normal
control while AGE-BSA as positive control. The primary antibody was replaced by 2% BSA in PBS for negative control.
Magnification 400 ×. Scale bars = 50 µm. B. Bar graphs show the average optical density of NF-ĸB p65 and nephrin per
glomerular. C. Expression ratio of NF-ĸB p65/nephrin. Data were expressed as mean ± SD. AGE = advanced glycation
end product; AGE-pAb = polyclonal anti-AGEs antibody; BSA = bovine serum albumin; CmL-mAb = monoclonal anti-
N-carboxymethyl-lysine antibody; NF-ĸB = nuclear factor-kappa B. *p < 0.05, vs BSA; **p < 0.05, vs AGE-BSA.
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Figure 2. AGEs antibody ameliorated glomerular cells apoptosis induced by AGEs. A. Images show glomeruli in either normal
condition or treated with AGE-BSA for 48 hours in the absence or presence of AGE-Ab. Apoptotic cells were stained
with FITC-conjugated Annexin V (shown in green) due to phosphatidylserine externalization and nephrin (shown in
red). Magnification 400  ×. Scale bars = 50 µm. B. Optical density of annexin V and nephrin was calculated using
ImageJ. C. Expression ratio of annexin V/nephrin. Data were expressed as mean ± SD. AGE = advanced glycation end
product; AGE-pAb = polyclonal anti-AGEs antibody; BSA = bovine serum albumin; CmL-mAb = monoclonal anti-N-
carboxymethyl-lysine antibody. *p < 0.05, vs BSA; **p < 0.05, vs AGE-BSA.
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suppressing the expression of glyoxalase which inacti-
vates the AGE precursor methylglyoxal [25]. RAGE ac-
tivation  in  mesangial  cells  increases  angiotensin-II
(Ang-II)  production  then  activates  trans-forming
growth factor-b–Smad signaling that  induces  mesan-
gial cell hypertrophy [26]. In addition, Ang-II induces
podocyte injury and nephrin inactivation (dephospho-
rylation)  through  caveolin-1-dependent  mechanism
and C-terminal-Src kinase- C-terminal-binding protein-
Fyn axis [27,28]. Reduction of nephrin surface expres-
sion is also induced by activation of protein kinase C-
mediated nephrin endocytosis [29]. Nephrin deficiency
activates NF-ĸB and disrupts clustering of membrane
raft  micro-domains  to  prevent  nephrin-mediated  sig-
naling, which affects the podo-cytes or other glomeru-
lar cells that interact with podo-cytes [30,31].
AGEs  antibody  ameliorated  AGEs-induced  apoptosis
of glomerular cells
Figure 2A-B illustrate the effect of AGEs and AGE-
Ab on apoptosis. AGE-BSA treatment resulted in a sig-
nificant increase of glomerular cells apoptosis and de-
crease of podocyte nephrin which significantly inhib-
ited  by  pre-incubation  of  AGE-Ab.  Previously  study
showed that AGE-BSA induces apoptosis by enhancing
FOXO4 binding to a forkhead binding ele-ment in the
promoter  of  Bcl2lll and increasing the acetylation of
FOXO4 at lysine residues mediated by downregulation
of  sirtuin  1  (SIRT1)  in  cultured  podocytes  and  in
glomeruli of diabetic patients [32]. Likewise, AGE-Ab
significantly reduced apoptosis/ nephrin expression ra-
tio  compared  with  AGE-BSA-treated  group  (Figure
2C).  Interestingly,  we found that nephrin expression
significantly preserved in the group of glomeruli under
AGE-mAb-treated group better than AGE-pAb-treated
group. These results suggested that AGE-Ab had a pro-
tective activity on AGEs-induced glomerular cells apop-
tosis and nephrin deple-tion.
The  correlation  between  NF-ĸB  p65  expression  and
apoptosis
A positive correlation was observed between NF-ĸB
p65 expression and apoptosis (r = 0.818) as well as be-
tween NF-ĸB/nephrin and apoptosis/nephrin ex-pres-
sion ratio (r = 0.828). Taken together, these data pro-
vided indirect evidence that AGE-Ab-mediated down-
regulation of NF-ĸB p65 expression may contri-bute to
inhibition of glomerular cells apoptosis.  The results of
the present study support the  protective  role of  AGE-
Ab against glomerular cells apoptosis, NF-ĸB p65 over-
expression and nephrin depletion induced by AGEs. In
this study,  we found that polyclonal  anti-AGEs anti-
body protects apoptosis and NF-ĸB p65 overexpression
better than monoclonal anti-CmL antibody. We specu-
late that AGE-IC formation contributes to these effects.
According  to  Mera  et  al.  [13],  we  hypothesize  that
polyclonal AGEs antibody recognizes multiple epitopes
on AGE-BSA, thus increases the formation of AGE-IC
which  induces  macrophages-mediated  AGE-BSA
phagocytosis  [13].  However,  activated  macrophages
can  downregulate  nephrin  expression  [33].  In  this
study,  monoclonal  CmL-specific  antibody  preserves
nephrin expression. CmL is one of the major immuno-
gen of  AGEs  that  accumulates  in all  renal  compart-
ment of diabetic patient. CmL increases expression of
ZEB2 by  NF-ĸB  activation  and  results  in  epithelial-
mesenchymal trans-formation of podocyte which is be-
lieved to play a vital role in podocyte depletion and the
pathogenesis of albuminuria during DN [34]. Our re-
sults showing only minor reduction of nephrin expres-
sion on pre-incubation of polyclonal  anti-AGEs anti-
body.  The  monoclonal  anti-CmL antibody  obviously
exerts pro-tective effect to podocyte with an aim to pre-
serve  nephrin  expression.  Previously  study  reported
that  both polyclonal  and monoclonal  anti-CmL anti-
body  have  a  significant  reactivity  to  CmL-proteins.
More-over, this monoclonal antibody significantly re-
acted with AGE-BSA as well as BSA modified by sev-
eral aldehydes such as glyoxal [35]. 
 
In conclusion, the present data confirm that pre-in-
cubation  of  AGEs  antibody  inhibits  apoptosis  and
NFĸB  p65  overexpression  in  glomeruli  exposed  to
AGEs. Our study demonstrates for the first time that
the antibody against AGEs may prevent AGEs-induced
glomerular damage.
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